Myeloid cell deficiency of p38γ/p38δ protects against candidiasis and regulates antifungal immunity
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Myeloid cell deficiency of p38γ/p38δ protects against candidiasis and regulates antifungal immunity ; volume:10 ; number:5 ; year:2018 ; extent:15
EMBO molecular medicine / European Molecular Biology Organization ; 10, Heft 5 (2018) (gesamt 15)
- Urheber
-
Alsina‐Beauchamp, Dayanira
Escós, Alejandra
Fajardo, Pilar
González‐Romero, Diego
Díaz‐Mora, Ester
Risco, Ana
Martín‐Serrano, Miguel A.
del Fresno, Carlos
Dominguez‐Andrés, Jorge
Aparicio, Noelia
Zur, Rafal
Shpiro, Natalia
Brown, Gordon D.
Ardavín, Carlos
Netea, Mihai G.
Alemany, Susana
Sanz‐Ezquerro, Juan J.
Cuenda, Ana
- DOI
-
10.15252/emmm.201708485
- URN
-
urn:nbn:de:101:1-2022090305575490642018
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:37 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Alsina‐Beauchamp, Dayanira
- Escós, Alejandra
- Fajardo, Pilar
- González‐Romero, Diego
- Díaz‐Mora, Ester
- Risco, Ana
- Martín‐Serrano, Miguel A.
- del Fresno, Carlos
- Dominguez‐Andrés, Jorge
- Aparicio, Noelia
- Zur, Rafal
- Shpiro, Natalia
- Brown, Gordon D.
- Ardavín, Carlos
- Netea, Mihai G.
- Alemany, Susana
- Sanz‐Ezquerro, Juan J.
- Cuenda, Ana
Ähnliche Objekte (12)
Molecular identification and antifungal susceptibility profile of yeast from vulvovaginal candidiasis
Antifungal activity of the piroctone olamine in experimental intra-abdominal candidiasis
Surgical management of chronic hyperplastic candidiasis refractory to systemic antifungal treatment
Vulvovaginal candidiasis: species distribution of Candida and their antifungal susceptibility pattern
Three-Dose Antifungal Treatment Improves the Efficacy for Severe Vulvovaginal Candidiasis
Natural killer cells in antifungal immunity
Correction to: Molecular identification and antifungal susceptibility profile of yeast from vulvovaginal candidiasis
Unconventional T cells – New players in antifungal immunity
Antifungal Effect of Long Noncoding RNA 9708-1 in the Vulvovaginal Candidiasis Murine Model
Myeloid CCN3 protects against aortic valve calcification
Plumieride as a novel anti-fungal and anti-inflammatory iridoid against superficial candidiasis in mice
Pharmacokinetic and pharmacodynamic considerations for antifungal therapy optimisation in the treatment of intra-abdominal candidiasis
Molecular identification and antifungal susceptibility profile of yeast from vulvovaginal candidiasis
Antifungal activity of the piroctone olamine in experimental intra-abdominal candidiasis
Surgical management of chronic hyperplastic candidiasis refractory to systemic antifungal treatment
Vulvovaginal candidiasis: species distribution of Candida and their antifungal susceptibility pattern
Three-Dose Antifungal Treatment Improves the Efficacy for Severe Vulvovaginal Candidiasis
Natural killer cells in antifungal immunity
Correction to: Molecular identification and antifungal susceptibility profile of yeast from vulvovaginal candidiasis
Unconventional T cells – New players in antifungal immunity
Antifungal Effect of Long Noncoding RNA 9708-1 in the Vulvovaginal Candidiasis Murine Model
Myeloid CCN3 protects against aortic valve calcification
Plumieride as a novel anti-fungal and anti-inflammatory iridoid against superficial candidiasis in mice
Pharmacokinetic and pharmacodynamic considerations for antifungal therapy optimisation in the treatment of intra-abdominal candidiasis
Molecular identification and antifungal susceptibility profile of yeast from vulvovaginal candidiasis
Antifungal activity of the piroctone olamine in experimental intra-abdominal candidiasis
Surgical management of chronic hyperplastic candidiasis refractory to systemic antifungal treatment
Vulvovaginal candidiasis: species distribution of Candida and their antifungal susceptibility pattern
Three-Dose Antifungal Treatment Improves the Efficacy for Severe Vulvovaginal Candidiasis
Natural killer cells in antifungal immunity
Correction to: Molecular identification and antifungal susceptibility profile of yeast from vulvovaginal candidiasis
Unconventional T cells – New players in antifungal immunity
Antifungal Effect of Long Noncoding RNA 9708-1 in the Vulvovaginal Candidiasis Murine Model
Myeloid CCN3 protects against aortic valve calcification
Plumieride as a novel anti-fungal and anti-inflammatory iridoid against superficial candidiasis in mice